Got Patients With Refractory axSpA or PsA? Consider This Option

(MedPage Today) — Although most patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA) didn’t respond adequately to the interleukin-17 (IL-17) inhibitor ixekizumab (Taltz), enough did that it should still be considered in such…

Source link : https://www.medpagetoday.com/rheumatology/arthritis/116666

Author :

Publish date : 2025-07-25 12:48:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Got Patients With Refractory axSpA or PsA? Consider This Option

Case Reports Describe Itch Relief With Nemolizumab

Hulk Hogan Dead at 71 Following Cardiac Arrest

Related Posts

‘My dad started spying on my mum’ – the drugs causing sexual urges

10,000 steps myth – should you be a stickler for recommended daily doses?

Why we need to talk about periods, breasts and injuries

Solar drone with wingspan wider than jumbo jet could fly for months

Study Touts Benefit of Mini Nonhormonal IUD — But It’s Not Sold in the U.S.

Negative social ties, like frenemies, could be ageing you

‘My dad started spying on my mum’ – the drugs causing sexual urges

10,000 steps myth – should you be a stickler for recommended daily doses?

Why we need to talk about periods, breasts and injuries

Solar drone with wingspan wider than jumbo jet could fly for months

Study Touts Benefit of Mini Nonhormonal IUD — But It’s Not Sold in the U.S.

Negative social ties, like frenemies, could be ageing you

Could Direct Primary Care’s Popularity Be on the Rise?

Will ‘Safe Staffing Committee’ Laws Help Reduce ED Wait Times?

Categories

Archives